Bone Biologics Corp - BBLG
Detailed investor-level table based on 13F positions.
Methodology:
Market value and % of portfolio use SEC reported VALUE ($000).
For PUT/CALL positions this reflects reported underlying exposure, not premium cash paid/received.
Details.
Rows: 0
| Investor | History | Status | Shares held | Market value ($000) | % of portfolio | Previous % | Rank | Change in shares | % change in shares | Source | Date reported |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DRW Securities, LLC | History | Added to | 23,576 | 34 | 0.0% | 0.0% | 1 | +12,549 | 113.8% | Q4 2025 | Feb 12, 2026 |
| TWO SIGMA INVESTMENTS, LP | History | New | 11,083 | 16 | 0.0% | — | 2 | +11,083 | New | Q4 2025 | Feb 17, 2026 |
| CITADEL ADVISORS LLC | History | New | 10,844 | 15 | 0.0% | — | 3 | +10,844 | New | Q4 2025 | Feb 17, 2026 |
| Tower Research Capital LLC (TRC) | History | Added to | 3,379 | 4 | 0.0% | 0.0% | 4 | +1,915 | 130.81% | Q4 2025 | Feb 17, 2026 |
| UBS Group AG | History | Added to | 1,948 | 2 | 0.0% | — | 5 | +1,882 | 2851.52% | Q4 2025 | Jan 29, 2026 |
| CITIGROUP INC | History | Closed out | 0 | 0 | — | — | — | -206 | -100.0% | Q3 2025 | Nov 10, 2025 |
| Clear Street Group Inc. | History | Closed out | 0 | 0 | — | — | — | -138 | -100.0% | Q3 2025 | Nov 14, 2025 |
| BANK OF AMERICA CORP /DE/ | History | No change | 14 | 0 | — | — | — | 0 | 0.0% | Q4 2025 | Feb 17, 2026 |
| SBI Securities Co., Ltd. | History | No change | 230 | 0 | — | — | — | 0 | 0.0% | Q4 2025 | Feb 03, 2026 |